Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Masamiki MORI"'
Autor:
Hiroko SAGARA, Kouji YOSHIKAWA, Isao TOMIZAWA, Yoshihiko TAKIZAWA, Yoshiro NITTA, Takafumi TSUNODA, Hiroyuki FUKUDA, Tsuyoshi YAMAGUCHI, Gohta MASUDA, Masayoshi NEGISHI, Atsushi AJISAWA, Misako MURATA, Kenji OHNISHI, Shoichiro IRIMAJIRI, Mitsuo OBANA, Fumio MATSUMOTO, Takero IMAI, Iwao SAKURAI, Takayuki TAKAHASHI, Masamiki MORI, Yoshiki MIZUNO, Kohji KATOH, Shiro HOSODA, Tadao BAMBA, Masaya SASAKI, Kunio YOSHIKAWA, Shuichi HIROTANI, Takeshi OGASAWARA, Hitoshi SAKUMOTO, Yasunobu KOMAI, Hideo OOKUBO, Young Ki KIM, Shinobu NAKAJO, Hirozumi OBATA, Yoshihiro SAKAUE, Hideki YOSHIDA, Tetsushi GOTO, Tadakazu AISAKA, Motoko MIKAMI, Kazunori KAGAWA, Yatsuka IMAGAWA, Masafumi FUKUYAMA, Yoshio MATSUBARA, Makoto SAITO
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 70:60-72
A clinical study was carried out on pazufloxacin (PZFX) in 137 patients including shigellosis, Salmonella enteritis, enteropathogenic Esherichia coli enteritis and cholera, and carriers of these pathogens. Antibacterial activity of PZFX against clini
Autor:
Mitsuo OBANA, Shoichiro IRIMAJIRI, Isao TOMIZAWA, Yoshihiko TAKIZAWA, Yumiko SAKAMOTO, Yoshiro NITTA, Takafumi TSUNODA, Hiroyuki FUKUDA, Tsuyoshi YAMAGUCHI, Gohta MASUDA, Masayoshi NEGISHI, Atsushi AJISAWA, Misako MURATA, Kenji OHNISHI, Hiroko SAGARA, Yoshikiyo SAJIMA, Fumio MATSUMOTO, Takero IMAI, Iwao SAKURAI, Takayuki TAKAHASHI, Koji KATO, Masamiki MORI, Shiro HOSODA, Tadao BAMBA, Masaya SASAKI, Kenichi TATEWAKI, Kenji FUSE, Hiroshi SAKUMOTO, Yoshiaki IWASAKI, Hideo OHKUBO, Yong-ki KIM, Mitsuru AKAO, Yoshihiro SAKAUE, Kaneko TOJO, Junko AMATSU, Hideki YOSHIDA, Kunio YOSHIKAWA, Tadakazu AISAKA, Motoko MIKAMI, Osamu KURIMURA, Kazunori KAGAWA, Yoshio MATSUBARA, Yatsuka IMAGAWA, Masafumi FUKUYAMA, Makoto SAITO
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 69:991-1006
The efficacy, safety and usefulness of balofloxacin (BLFX) for patients with acute infectious enteritis and the carriers mainly shigellosis, were investigated. The drug was administered at a daily dose of 200 mg twice a day for 3 days to patients wit
Autor:
Etsuro Orito, Kaoru Suzuki, Shiro Iino, Koji Kato, Masamiki Mori, Tomoyoshi Ohno, Masashi Mizokami, Ken-ichi Ohba, Katsuo Hayashi, Johnson Y.N. Lau
Publikováno v:
Journal of medical virology. 46(2)
To determine the virological factors associated with a favorable long-term response to interferon-alpha (IFN) therapy in chronic hepatitis C virus (HCV) infection, 61 Japanese patients with chronic HCV infection were treated with IFN for 24 weeks (78